MedTrace Logo

Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia

NCT00900224 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 529

Last updated 2023-08-31

No results posted yet for this study

Summary

RATIONALE: Studying samples of tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is looking at tissue and blood samples from patients with acute myeloid leukemia.

Conditions

Interventions

GENETIC

DNA analysis

GENETIC

DNA methylation analysis

GENETIC

gene expression analysis

GENETIC

mutation analysis

GENETIC

polymerase chain reaction

GENETIC

reverse transcriptase-polymerase chain reaction

OTHER

high performance liquid chromatography

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Alliance for Clinical Trials in Oncology

    lead OTHER

Principal Investigators

  • Clara Bloomfield, MD · Ohio State University Comprehensive Cancer Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00900224 on ClinicalTrials.gov